|
|
|
13.01.26 - 23:36
|
Blue Matter ergänzt neue Fähigkeiten in der biopharmazeutischen Forschung und Entwicklung unter der Führung von Partnerin Tara Austraat-Churik (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Blue Matter hat einen neuen Praxisbereich gegründet, der auf die Bedürfnisse von Kunden aus der biopharmazeutischen Forschung und Entwicklung (FuE) ausgerichtet ist. Geleitet wird der Praxisbereich von Tara Austraat-Churik, einer Partnerin, die seit September 2025 für Blue Matter tätig ist.
Tara Austraat-Churik ist bereits seit über 20 Jahren für Life-Science-Kunden tätig. Ihre Schwerpunkte sind Strategieentwicklung und -umsetzung, Betriebsmodell- und Organisationsgestaltung sowie Prozessoptimierung in den Bereichen Forschung und Entwicklung sowie Medical Affairs. Bevor sie zu Blue Matter wechselte, war sie als Managing Director im Bereich Forschung und Entwicklung, Gesundheit, Wissenschaft und Wellness bei EY tätig. Sie bringt umfangreiche Erfahrungen im Consulting-Bereich mit, die sie unter anderem bei Booz Allen Hamilton, Navitas, WPP und IBM sammeln konnte. Sie hat einen BA- und MA-Abschluss der University of Notre Dame und einen MSc-Abschluss in translationaler Medi...
|
|
|
|
|
|
|
|
|
13.01.26 - 15:03
|
Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025.
Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh.
The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “...
|
|
|
|
|
|
|
|
|
13.01.26 - 00:54
|
Column: IBM′s 50-year-old liquid cooling patent shapes today′s AI data center cooling (Digitimes)
|
|
|
If today's AI data centers are blazing "powder kegs" of heat, IBM was the visionary that prepared the "fire extinguisher" half a century ago. While Nvidia's top chips now require water cooling to operate, few realize that this technology's "biological father" actually dates back to IBM in the 1960s. Today, we explore this groundbreaking US patent 3,524,497 ("Patent 497") and its blue-cooling revolution spanning over 50 years....
|
|
|
12.01.26 - 22:09
|
Confluent to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 11, 2026 (Business Wire)
|
|
|
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced it will release financial results for its fourth quarter and fiscal year 2025, which ended December 31, 2025, after the U.S. market close on Wednesday, February 11, 2026.
In light of the pending transaction with IBM, Confluent will not be hosting an earnings conference call to review the results or providing a financial outlook.
About Confluent
Confluent is the data streaming platform that is pioneering a fundamentally new category of data infrastructure that sets data in motion. Confluent's cloud-native offering is the foundational platform for data in motion – designed to be the intelligent connective tissue enabling real-time data, from multiple sources, to constantly stream across the organization. With Confluent, organizations can meet the new business imperative of delivering rich, digital front-end customer experiences and transitioning to sophisticated, real-time, software-driven ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|